Evaluation of Diversity of Clinical Trials Informing Health Technology Assessments in the United States: A 5-Year Analysis of Institute for Clinical and Economic Review Assessments
Authors:
- 25 May 2023
- journal article
- review article
- Published by Elsevier in Value in Health
- Vol. 26 (9) , 1345-1352
Abstract
No abstract availableKeywords
Funding Information
- Commonwealth Fund
This publication has 25 references indexed in Scilit:
- African American ancestry contribution to asthma and atopic dermatitisAnnals of Allergy, Asthma & Immunology, 2019
- The More Things Change, the More They Stay the Same: A Study to Evaluate Compliance With Inclusion and Assessment of Women and Minorities in Randomized Controlled TrialsAcademic Medicine, 2018
- Demographics of Clinical Trials Participants in Pivotal Clinical Trials for New Molecular Entity Drugs and Biologics Approved by FDA From 2010 to 2012American Journal of Therapeutics, 2015
- Twenty years post‐NIH Revitalization Act: Enhancing minority participation in clinical trials (EMPaCT): Laying the groundwork for improving minority clinical trial accrualCancer, 2014
- Participation of Women and Sex Analyses in Late-Phase Clinical Trials of New Molecular Entity Drugs and Biologics Approved by the FDA in 2007–2009Journal of Women's Health, 2013
- Impact of Race on Asthma Treatment Failures in the Asthma Clinical Research NetworkAmerican Journal of Respiratory and Critical Care Medicine, 2011
- Inclusion, Analysis, and Reporting of Sex and Race/Ethnicity in Clinical Trials: Have We Made Progress?Journal of Women's Health, 2011
- Influence of race/ethnicity on response to lupus nephritis treatment: the ALMS studyRheumatology, 2009
- Systematic Review of Barriers to the Recruitment of Older Patients With Cancer Onto Clinical TrialsJournal of Clinical Oncology, 2005
- Adequacy of reporting race/ethnicity in clinical trials in areas of health disparitiesJournal of Clinical Epidemiology, 2003